Steven Marotta
Stock Analyst at CL King
(0.59)
# 3,712
Out of 4,748 analysts
15
Total ratings
37.5%
Success rate
-15.08%
Average return
Main Sectors:
Stocks Rated by Steven Marotta
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GIII G-III Apparel Group | Downgrades: Neutral | n/a | $32.47 | - | 1 | Dec 1, 2022 | |
| SHOO Steven Madden | Upgrades: Buy | n/a | $41.32 | - | 1 | Sep 28, 2022 | |
| CTKB Cytek Biosciences | Initiates: Overweight | $28 | $5.69 | +392.09% | 1 | Aug 17, 2021 | |
| AVTR Avantor | Upgrades: Overweight | $32 → $41 | $21.49 | +90.79% | 3 | Aug 2, 2021 | |
| CAL Caleres | Upgrades: Buy | $29 | $19.04 | +52.31% | 2 | Jun 1, 2021 | |
| CROX Crocs | Downgrades: Neutral | n/a | $104.77 | - | 3 | Jul 17, 2020 | |
| GCO Genesco | Upgrades: Buy | n/a | $41.83 | - | 4 | Jan 21, 2020 |
G-III Apparel Group
Dec 1, 2022
Downgrades: Neutral
Price Target: n/a
Current: $32.47
Upside: -
Steven Madden
Sep 28, 2022
Upgrades: Buy
Price Target: n/a
Current: $41.32
Upside: -
Cytek Biosciences
Aug 17, 2021
Initiates: Overweight
Price Target: $28
Current: $5.69
Upside: +392.09%
Avantor
Aug 2, 2021
Upgrades: Overweight
Price Target: $32 → $41
Current: $21.49
Upside: +90.79%
Caleres
Jun 1, 2021
Upgrades: Buy
Price Target: $29
Current: $19.04
Upside: +52.31%
Crocs
Jul 17, 2020
Downgrades: Neutral
Price Target: n/a
Current: $104.77
Upside: -
Genesco
Jan 21, 2020
Upgrades: Buy
Price Target: n/a
Current: $41.83
Upside: -